Subin is a PhD candidate in Cancer Systems Biology at MD Anderson Cancer Center studying genetic interactions and cancer-specific vulnerabilities using combinatorial CRISPR perturbation screens and large-scale functional genomics. Her work examines why most genetic hits fail to translate therapeutically and how mapping higher-order interactions can expose the dependencies that single knockouts mask. Prior to MD Anderson, she trained at UC Berkeley and Stanford in aging biology and cancer immunology. She is active in the early-stage biotech ecosystem through Nucleate and is drawn to building technologies that make biological discovery more measurable and decision-driven.